AstraZeneca Covid vaccine sales jump to $894 mln, updates forecasts
AstraZeneca's Covid-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months but shaved off 1 US cent from earnings, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexion unit.